Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Muller

Showing results (311-320 of 923) with videos related to

Pageof 93
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1997
Anti-HIV-1 activity of inorganic polyphosphatesB Lorenz, J Leuck, D Köhl, et al.
Environmental Research|April 1, 1984
Toluene blood level following subcutaneous injection of toluene in the ratV A Benignus, K E Muller, C N Barton, et al.
Circulation|April 1, 1981
Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery diseaseS Gunther, L Green, J E Muller, et al.
Neurotoxicology and Teratology|March 1, 1988
The effects of low-level carbon monoxide exposure upon evoked cortical potentials in young and elderly menT J Harbin, V A Benignus, K E Muller, et al.
Biometrics|November 7, 2003
A new method for choosing sample size for confidence interval-based inferencesMichael R Jiroutek, Keith E Muller, Lawrence L Kupper, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Some relationships between endorphins and pituitary hormonesA Santagostino, D Cocchi, G Giagnoni, et al.
Pharmacotherapy|September 1, 1981
Nifedipine in the treatment of cardiovascular diseaseH S Mueller, E M Antman, J A Ferst, et al.
Journal of the American College of Cardiology|March 31, 2007
ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseasesJoseph P Ornato, James E Muller, Erika S Froelicher, et al.
Journal of Applied Statistics|October 25, 2014
Separability tests for high-dimensional, low sample size multivariate repeated measures dataSean L Simpson, Lloyd J Edwards, Martin A Styner, et al.
The Journal of Antimicrobial Chemotherapy|March 20, 2024
Towards optimizing cefepime/tazobactam (WCK 4282) exposure to achieve efficacy against piperacillin/tazobactam-resistant ESBL infections: dose recommendations for various renal functions, including intermittent haemodialysis, in healthy individualsAnouk E Muller, Brenda C M De Winter, Birgit C P Koch
Pageof 93

Showing results (311-320 of 923) with videos related to

Sort By:
Pageof 93
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1997
Anti-HIV-1 activity of inorganic polyphosphatesB Lorenz, J Leuck, D Köhl, et al.
Environmental Research|April 1, 1984
Toluene blood level following subcutaneous injection of toluene in the ratV A Benignus, K E Muller, C N Barton, et al.
Circulation|April 1, 1981
Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery diseaseS Gunther, L Green, J E Muller, et al.
Neurotoxicology and Teratology|March 1, 1988
The effects of low-level carbon monoxide exposure upon evoked cortical potentials in young and elderly menT J Harbin, V A Benignus, K E Muller, et al.
Biometrics|November 7, 2003
A new method for choosing sample size for confidence interval-based inferencesMichael R Jiroutek, Keith E Muller, Lawrence L Kupper, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Some relationships between endorphins and pituitary hormonesA Santagostino, D Cocchi, G Giagnoni, et al.
Pharmacotherapy|September 1, 1981
Nifedipine in the treatment of cardiovascular diseaseH S Mueller, E M Antman, J A Ferst, et al.
Journal of the American College of Cardiology|March 31, 2007
ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseasesJoseph P Ornato, James E Muller, Erika S Froelicher, et al.
Journal of Applied Statistics|October 25, 2014
Separability tests for high-dimensional, low sample size multivariate repeated measures dataSean L Simpson, Lloyd J Edwards, Martin A Styner, et al.
The Journal of Antimicrobial Chemotherapy|March 20, 2024
Towards optimizing cefepime/tazobactam (WCK 4282) exposure to achieve efficacy against piperacillin/tazobactam-resistant ESBL infections: dose recommendations for various renal functions, including intermittent haemodialysis, in healthy individualsAnouk E Muller, Brenda C M De Winter, Birgit C P Koch
Pageof 93